Bruce Rogers Biography and Net Worth

Insider of Morphic

Bruce Rogers, PhD is Chief Scientific Officer at Morphic Therapeutic Inc. He brings over 20 years of drug discovery experience across pre-clinical and early stage clinical development programs, medicinal chemistry, biology, partnering and R&D strategy. He was most recently the Head of Neuro-Opportunities at Pfizer, where he led a team focused on entrepreneurial approaches to long standing CNS biology challenges, including direct brain delivery of protein therapeutics for PD and oncology approaches. Bruce spent 16 years in positions of increasing responsibility within the medicinal chemistry organization at Pfizer and Pharmacia, and during his time there led multiple discovery and early clinical development teams, with his group advancing over a dozen small molecule candidates into clinical trials for a broad range of neuroscience indications. Bruce has co-authored more than 50 scientific publications, reviews and abstracts and is a co-inventor on over 40 patents and patent applications. He holds a BA in chemistry from the University of Minnesota, a PhD in organic chemistry from the University of California at Irvine. He was a National Institutes of Health postdoctoral fellow at the University of California prior to joining the pharmaceutical industry.

What is Bruce Rogers' net worth?: The estimated net worth of Bruce Rogers is at least $3.97 million as of January 16th, 2024. Dr. Rogers owns 142,036 shares of Morphic stock worth more than $3,974,167 as of April 25th. This net worth estimate does not reflect any other investments that Dr. Rogers may own. Additionally, Dr. Rogers receives a salary of $787,880.00 as Insider at Morphic. Learn More about Bruce Rogers' net worth.
How old is Bruce Rogers?: Dr. Rogers is currently 55 years old. There are 5 older executives and no younger executives at Morphic. The oldest executive at Morphic is Dr. Timothy A. Springer Ph.D., Founder, Independent Director & Member of Scientific Advisory Board, who is 76 years old. Learn More on Bruce Rogers' age.
What is Bruce Rogers' salary?: As the Insider of Morphic Holding, Inc., Dr. Rogers earns $787,880.00 per year. The highest earning executive at Morphic is Dr. Praveen P. Tipirneni M.D., CEO, MD & Director, who commands a salary of $991,330.00 per year. Learn More on Bruce Rogers' salary.
How do I contact Bruce Rogers?: The corporate mailing address for Dr. Rogers and other Morphic executives is 35 Gatehouse Drive A2, Waltham MA, 02451. Morphic can also be reached via phone at (781) 996-0955. Learn More on Bruce Rogers' contact information.
Has Bruce Rogers been buying or selling shares of Morphic?: Bruce Rogers has not been actively trading shares of Morphic during the past quarter. Most recently, Bruce Rogers sold 6,314 shares of the business's stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $27.49, for a transaction totalling $173,571.86. Following the completion of the sale, the president now directly owns 142,036 shares of the company's stock, valued at $3,904,569.64. Learn More on Bruce Rogers' trading history.
Who are Morphic's active insiders?: Morphic's insider roster includes Robert Farrell, Jr. (CAO), Peter Linde (Insider), Bruce Rogers (Insider), Marc Schegerin (CFO), and Timothy Springer (Director). Learn More on Morphic's active insiders.
Are insiders buying or selling shares of Morphic?: During the last twelve months, Morphic insiders bought shares 2 times. They purchased a total of 1,052,400 shares worth more than $47,299,440.00. During the last twelve months, insiders at the sold shares 18 times. They sold a total of 207,841 shares worth more than $10,448,821.11. The most recent insider tranaction occured on January, 16th when CEO Praveen P Tipirneni sold 13,923 shares worth more than $382,743.27. Insiders at Morphic own 28.1% of the company. Learn More about insider trades at Morphic.
Information on this page was last updated on 1/16/2024.

Bruce Rogers Insider Trading History at Morphic

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Sell	6,314	$27.49	$173,571.86	142,036
4/25/2023	Sell	30,000	$53.40	$1,602,000.00	117,055
4/17/2023	Sell	10,000	$40.35	$403,500.00	117,055
2/14/2023	Sell	10,000	$40.09	$400,900.00	116,192
1/14/2023	Sell	1,778	$30.63	$54,460.14	116,192
4/1/2022	Sell	10,000	$41.03	$410,300.00
9/13/2021	Sell	1,721	$65.00	$111,865.00
9/10/2021	Sell	8,279	$65.11	$539,045.69
3/15/2021	Sell	8,509	$65.60	$558,190.40
2/8/2021	Sell	4,654	$40.03	$186,299.62	104,451
1/6/2021	Sell	11,240	$30.19	$339,335.60	109,105
1/4/2021	Sell	11,950	$32.72	$391,004.00
6/10/2020	Sell	25,000	$23.33	$583,250.00	157,018
5/28/2020	Sell	20,000	$22.55	$451,000.00

Bruce Rogers Buying and Selling Activity at Morphic

Morphic Company Overview

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4ß7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avß8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrödinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $27.98

$26.36

$28.11

50 Day Range

MA: $33.33

$27.51

$39.53

2 Week Range

Now: $27.98

$19.34

$63.08

Volume

772,240 shs

Average Volume

505,297 shs

Market Capitalization

$1.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.42

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

Bruce Rogers Biography and Net Worth

What is Bruce Rogers' net worth?

How old is Bruce Rogers?

What is Bruce Rogers' salary?

How do I contact Bruce Rogers?

Has Bruce Rogers been buying or selling shares of Morphic?

Who are Morphic's active insiders?

Are insiders buying or selling shares of Morphic?